Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Refractory Shock

Sindhu Barola  1 , Nadeem Shabbir  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Book

Refractory Shock

Sindhu Barola et al.

Excerpt

Shock is a condition when there is a discrepancy between the needs of the tissues and their supply of oxygen and nutrients. It is due to the dysfunction of the circulatory system in providing blood to the tissues to adequately meet the metabolic requirements and the insufficient removal of waste products of metabolism. The most common cause of shock in the pediatric population is hypovolemic shock, whereas, in adults, it is septic shock. Refractory shock is variably defined as persistent hypotension with end-organ dysfunction despite fluid resuscitation, high-dose vasopressors, oxygenation, and ventilation. Fluid resuscitation and vasopressors are the initial approaches to the management of shock. Overuse of fluids in critically ill patients can lead to pulmonary edema, hypoxemic respiratory failure, and organ edema.

High doses of catecholamines can induce arrhythmias and ischemia. The strongest predictor of mortality in critically ill patients is the vasopressor dose that is required to maintain the mean arterial pressure (MAP) goal. High dose vasopressor doses can be defined by converting other vasopressors to norepinephrine equivalents of > 0.2 micrograms/kg/min. There are no standard guidelines for the management of refractory shock, but a few randomized studies guide clinical management.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Sindhu Barola declares no relevant financial relationships with ineligible companies.

Disclosure: Nadeem Shabbir declares no relevant financial relationships with ineligible companies.

References

    1. Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, Van Regenmortel N. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):361-80. - PubMed
    1. Schmittinger CA, Torgersen C, Luckner G, Schröder DC, Lorenz I, Dünser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med. 2012 Jun;38(6):950-8. - PubMed
    1. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II Investigators Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010 Mar 04;362(9):779-89. - PubMed
    1. Jenkins CR, Gomersall CD, Leung P, Joynt GM. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study. Anaesth Intensive Care. 2009 Mar;37(2):286-9. - PubMed
    1. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87. - PubMed

Publication types